Beam Therapeutics Inc. Debt/Assets

Debt/Assets of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt/Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Debt/Assets for the quarter ending September 30, 2022 was 13.18% (a 5.02% increase compared to previous quarter)
  • Year-over-year quarterly Debt/Assets increased by 31.27%
  • Annual Debt/Assets for 2021 was 10.04% (a -57.62% decrease from previous year)
  • Annual Debt/Assets for 2020 was 23.69% (a 15.56% increase from previous year)
  • Annual Debt/Assets for 2019 was 20.5% (a Infinity% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt/Assets of Beam Therapeutics Inc.

Most recent Debt/Assetsof BEAM including historical data for past 10 years.

Interactive Chart of Debt/Assets of Beam Therapeutics Inc.

Beam Therapeutics Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 13.18% 12.55% 10.32%
2021 10.04% 12.62% 16.01% 19.76% 10.04%
2020 23.69% 12.22% 12.06% 11.08% 23.69%
2019 20.01% 0.0% 0.0% 0.0% 20.5%
2018 0.0% 0.0%
2017 50.0%

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology